In conclusion, all data in this study suggest that EBR is an effective apoptotic agent through modulating the CALR expression profile and thus causing deficient Ca2+ buffering potential regardless of NHR expression in prostate cancer cells (Fig 8). Here, CALR is linked to prostate carcinoma.